Evidence map›Paper›PMID 34596082›Full record

SynthesisJournal of the Chinese Medical Association : JCMA2021

Evaluation of the diagnostic accuracy of COVID-19 antigen tests: A systematic review and meta-analysis.

Yuan-Hung Wang, Chia-Chang Wu, Chyi-Huey Bai, Shou-Cheng Lu, Yi-Ping Yang, Yi-Ying Lin, Wei-Yi Lai, Tzu-Wei Lin, Ying-Chun Jheng, Ming-Cheng Lee and 1 more

Open access · hybridAbstract readEvaluation StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of the Chinese Medical Association : JCMA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 4 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 4 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Investigation of the diagnostic performance of the SARS-CoV-2 saliva antigen test: A meta-analysis.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Cost-effectiveness analysis of COVID-19 tests in the unified health system.Cost effectiveness and resource allocation : C/E · 2023
    Article
  8. Article
  9. Article
  10. Development of a high-sensitivity and short-duration fluorescenceFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yuan-Hung WangGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC.
Chia-Chang WuDepartment of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC.
Chyi-Huey BaiDepartment of Public Health, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC.
Shou-Cheng LuDepartment of Laboratory Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, ROC.
Yi-Ping YangDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Yi-Ying LinDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Wei-Yi LaiDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Tzu-Wei LinDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Ying-Chun JhengDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Ming-Cheng LeeDepartment of Medicine, Cheng Hsin General Hospital, Taipei, Taiwan, ROC.
Cheng-Chieh ChenGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, ROC.
Taipei Veterans General Hospital · TWTaipei Medical University-Shuang Ho Hospital · TWTaipei Medical University · TWCheng Hsin General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) pandemic continues to affect countries worldwide. To inhibit the transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), testing of patients, contact tracing, and quarantine of their close contacts have been used as major nonpharmaceutical interventions. The advantages of antigen tests, such as low cost and rapid turnaround, may allow for the rapid identification of larger numbers of infectious persons. This meta-analysis aimed to evaluate the diagnostic accuracy of antigen tests for SARS-CoV-2.

methodsWe searched PubMed, Embase, Cochrane Library, and Biomed Central databases from inception to January 2, 2021. Studies evaluating the diagnostic accuracy of antigen testing for SARS-CoV-2 with reference standards were included. We included studies that provided sufficient data to construct a 2 × 2 table on a per-patient basis. Only articles in English were reviewed. Summary sensitivity and specificity for antigen tests were generated using a random-effects model.

resultsFourteen studies with 8624 participants were included. The meta-analysis for antigen testing generated a pooled sensitivity of 79% (95% CI, 66%-88%; 14 studies, 8624 patients) and a pooled specificity of 100% (95% CI, 99%-100%; 14 studies, 8624 patients). The subgroup analysis of studies that reported specimen collection within 7 days after symptom onset showed a pooled sensitivity of 95% (95% CI, 78%-99%; four studies, 1342 patients) and pooled specificity of 100% (95% CI, 97%-100%; four studies, 1342 patients). Regarding the applicability, the patient selection, index tests, and reference standards of studies in our meta-analysis matched the review title.

conclusionAntigen tests have moderate sensitivity and high specificity for the detection of SARS-CoV-2. Antigen tests might have a higher sensitivity in detecting SARS-CoV-2 within 7 days after symptom onset. Based on our findings, antigen testing might be an effective method for identifying contagious individuals to block SARS-CoV-2 transmission.

Indexed as

Antigens, ViralCOVID-19COVID-19 Serological TestingHumansSARS-CoV-2Sensitivity and SpecificityAntigens, Viral

Identifiers

PMID34596082
PMCPMC12966028
OpenAlexW3202390713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.